This study examines the effect of the COVID-19 pandemic on the performance of the main indices and corporate returns in Jordan. The study employs two samples and two levels of analysis. The first one considers the effect of daily cumulative confirmed cases of COVID-19 on the daily return of the main index and sub-indices of the Amman Stock Exchange (ASE). The time-series analysis shows that there is a strong negative impact of the daily cumulative confirmed cases of COVID-19 on the daily return of the Amman Stock Exchange index. The results also indicate that the financial sector is the most affected during the epidemic, followed by the service and industry sectors. The insurance sector is positively affected, but not statistically significant.The second level of analysis aims to test how different corporate financial characteristics might affect corporate immunity during the pandemic period. The sample includes all non-financial firms listed on ASE, with a total of 75 firms. Based on quarterly data, the findings show a statistically significant negative effect of the COVID-19 pandemic on non-financial corporate stock returns. Further, the evidence shows that larger firms with higher levels of cash holding have better immunity and thus experience higher returns during the pandemic period.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.